fashion -WSS

fashion

author：Wikipedia 2025-09-27 23:03:40 - browse：525

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

explore

WSS

Covid misinformation case heads to Supreme Court

Vertigo drug brings hope for rare neuron disorder, Niemann

The lessons of Aduhelm, an Alzheimer's drug that was not to be

ARCH Venture Partners is raising $3 billion for a life sciences fund

Congressmen charge Covid hearing ‘could have been an email’

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

fashion

hotspot

Virginia high school admissions case could be legal follow

Congressmen charge Covid hearing ‘could have been an email’

Sports medicine is finally prioritizing gender equality

The real point of Kenneth Smith’s execution by nitrogen gas

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Congressmen charge Covid hearing ‘could have been an email’

23andMe had bad news about my health. I wish a person had delivered it

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Trump demands the U.S. pay no more for drugs than other countries … again

The real point of Kenneth Smith’s execution by nitrogen gas

entertainment

Apple Vision Pro: A first look at health apps on the new VR headset

Medicare drug price negotiation’s day in court

Medicare drug price negotiation’s day in court

FDA drug safety: Singulair case shows systemic surveillance flaws

Juul spent big to court Black leaders to promote its e

SAMSHA loosens regulations on methadone treatment centers

hotspot

knowledge

explore

knowledge